Villanego, F, Mazuecos, A, Perez-Flores, IM, Moreso, F, Andres, A, Jimenez-Martin, C, Molina, M, Canal, C, Sanchez-Camara, LA, Zarraga, S, Ruiz-Fuentes, MD, Aladren, MJ, Melilli, E, Lopez, V, Sanchez-Alvarez, E, Crespo, M, Pascual, J. Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: Analysis of the Spanish Registry. AMERICAN JOURNAL OF TRANSPLANTATION. 2021; 21(7)DOI:10.1111/ajt.16579. PMID:33756067. IF:9.369(Q1/1D).

Domingo-Gallego, A, Pybus, M, Madariaga, L, Pinero-Fernandez, JA, Gonzalez-Pastor, S, Lopez-Gonzalez, M, Simarro-Rueda, E, Quintanilla-Mata, ML, Matoses-Ruiperez, ML, Ejarque-Vila, L, Cornec-Le Gall, E, Guirado, L, Torra, R, Ariceta, G, Ars, E. Clinical and genetic characterization of a cohort of proteinuric patients with biallelic CUBN variants. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022; 37(10)DOI:10.1093/ndt/gfab285. PMID:34610128. IF:6.100(Q1/2D).

Naranjo, J, Furlano, M, Torres, F, Hernandez, J, Pybus, M, Ejarque, L, Cordoba, C, Guirado, L, Ars, E, Torra, R. Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney disease. Clinical Kidney Journal. 2022; 15(5)DOI:10.1093/ckj/sfab293. PMID:35498884. IF:4.600(Q1/2D).

Muller, RU, Messchendorp, AL, Birn, H, Capasso, G, Cornec-Le Gall, E, Devuyst, O, van Eerde, A, Guirchoun, P, Harris, T, Hoorn, EJ, Knoers, NVAM, Korst, U, Mekahli, D, Le Meur, Y, Nijenhuis, T, Ong, ACM, Sayer, JA, Schaefer, F, Servais, A, Tesar, V, Torra, R, Walsh, SB, Gansevoort, RT. An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022; 37(5)DOI:10.1093/ndt/gfab312. PMID:35134221. IF:6.100(Q1/2D).